Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and... see more

TSXV:RHT.H - Post Discussion

View:
Post by lscfa on Dec 11, 2022 11:54pm

2023 guidance

Why is this not widely disclosed to the public? Selective disclosure is illegal. Is co. now saying 2023 revenue will be at least $51 million for sass + $15 for devices?




Revenue guidance for Calendar 2022 will be delayed but as expected Calendar 2023 will exceed Calendar 2022 forecasted revenue with the current run rate of >$3 million a quarter, $15 million in announced device sales and another $15 million in SAAS and professional services revenue associated with those device sales and that doesn’t include any growth.
 

https://themoneynarrative.wordpress.com/2022/11/30/reliq-health-technologies-rht-v-thoughts-on-the-q1-fy2023-financials/#more-3756

Comment by lscfa on Dec 11, 2022 11:56pm
Correction: 2023 sass revenue = $3 mil x 4 qtrs + $15 = $27 mil
Comment by qwerty22 on Dec 12, 2022 9:14am
"While the current pool of investors may not understand the fantastic growth and business Reliq is building and may have had unrealistic expectations that a small company in a new market with primarily retail shareholders would not have a few missteps" It's all your own fault guys. Wonder where those unrealistic expectations came from?
Comment by qwerty22 on Dec 12, 2022 10:57am
The question is where do the unrealistic expectations end. Are we meant to believe they are all behind us?  What are the expectations now? That the revenue that didn't come in 22 will turn up in the next two quarters. Is this realistic? Or just more unrealistic expectations? It's being set by exactly the same person who set the previous expectations. Can we trust these expectations? ...more  
Comment by Lifeboat1 on Dec 12, 2022 11:14am
Qwerty22.  The Money Narrative comments tell you everything you need to know.  The Company is on the trajectory they have been saying for the past three years and have hit the first and will most likely hit the others just a little slower than initially expected.  As the article stated, calendar 2022 revenue will exceed the forecast originally expected for 2021 and 2023 revenue will ...more  
Comment by qwerty22 on Dec 12, 2022 3:06pm
Sure, well it's easy to see one thing is bigger than another thing, but in reality we are talking about 1/2 mil $ increase over a few quarters and big chunks of that is hardware when it's the software that we are all here for. It's a cleverer man than me who can see the trajectory here. If Reliq is an engine, we can see the fuel going in (contracts) but we can't see the power ...more  
Comment by lscfa on Dec 12, 2022 3:13pm
What trajectory?    Co. said the run rate at Dec 31/2021 was $2 million/month. Now they say it is currently $3 million/QUARTER !!!
Comment by Lifeboat1 on Dec 12, 2022 4:41pm
Fiscal year / Revenue. 2021 1.5 million 2022 8.5 million 2023 > 27 million ($15 million plus at least $12 million)
Comment by Lifeboat1 on Dec 12, 2022 10:57am
IFSCA - It has been disclosed.  All of those numbers are publicly available.  You really look for any reason to try make something out of nothing. 
Comment by EdinColorado on Dec 12, 2022 1:45pm
But not without reason. The revenue projections and overpromises have indeed been an effort to create something out of nothing. The overpromises to date were based on stories and acts offered so often that they are no longer working with investors. I'll agree that they are on a right trajectory but the execution to date has cost both the company and stockholders credibility. The overpromising ...more  
Comment by qwerty22 on Dec 12, 2022 3:11pm
I want the overpromising to stop as well but it's the best thing they have right now. Without it all we have are the mis-steps (and hurricanes and pandemics). (Any way she can drag the Hawaii volcano into this as well?)  
Comment by kepiyal on Dec 12, 2022 12:57am
This post has been removed in accordance with Community Policy
Comment by Lifeboat1 on Dec 12, 2022 11:04am
Iscfa - the Company guidance based on the recent press release and the info on the website is between $40 and > $100 million for 2023 per all the disclosures of which > $50 million falls between those numbers.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities